Mesothelioma

Cisplatin, Pemetrexed And Bevacizumab News

Eli Lilly: Alimta receives US green light for lung cancerThursday, October 2, 2008 @ 6:49PMAlimta has received US approval for use as a first-line therapy in locally advanced and metastatic non-small cell lung cancer in combination with cisplatin. This third FDA approval for Alimta follows its prominent use in patients with non-squamous carcinoma cell histology and highlights the shift towards a more tailored approach for lung cancer therapy.

Significant Data on ERBITUX(R) (cetuximab) and ImClone Pipeline to Be Presented at American Society of Clinical ...Friday, May 16, 2008 @ 6:44AMImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that significant scientific data on ERBITUX(R) (cetuximab) will be presented at the American Society of Clinical Oncology (ASCO) 2008 Annual Meeting taking place May 30 through June 3, 2008 in Chicago. In total, ImClone and its partners ...

Significant Data on ERBITUX(R) (cetuximab) and ImClone Pipeline to Be Presented at American Society of Clinical ...Friday, May 16, 2008 @ 6:30AM NEW YORK----ImClone Systems Incorporated , a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that significant scientific data on ERBITUX® will be presented at the American Society of Clinical Oncology 2008 Annual Meeting taking place May 30 through June 3, 2008 in Chicago.